Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/24/2012 | CA2342289C Treatment of cervical cancer |
07/24/2012 | CA2339411C Engraftable human neural stem cells |
07/24/2012 | CA2315538C Neural precursor cells, method for the production and use thereof in neural defect therapy |
07/19/2012 | WO2012097371A2 Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis |
07/19/2012 | WO2012097331A1 Methods for increasing reticulocyte hemoglobin content |
07/19/2012 | WO2012097330A2 Compositions and methods for treating degenerative muscle conditions |
07/19/2012 | WO2012097329A1 Methods for increasing mean corpuscular volume |
07/19/2012 | WO2012097281A2 Injectable filler for podiatric and orthopedic uses |
07/19/2012 | WO2012097273A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
07/19/2012 | WO2012097270A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
07/19/2012 | WO2012097269A1 Pyrimidine gyrase and topoisomerase iv inhibitors |
07/19/2012 | WO2012097261A2 Methods targeting mir-128 for regulating cholesterol/lipid metabolism |
07/19/2012 | WO2012097258A2 Formulations for the prevention and treatment of wolbachia-related disease |
07/19/2012 | WO2012097223A2 Oligosaccharide conjugates for targeting bacteria and uses related thereto |
07/19/2012 | WO2012097222A1 High drug load tablet formulation of brivanib alaninate |
07/19/2012 | WO2012097197A1 Donepezil transdermal patch |
07/19/2012 | WO2012097196A1 Pyrazolopyrimidine derivatives and uses as anticancer agents |
07/19/2012 | WO2012097182A1 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators |
07/19/2012 | WO2012097177A2 Substituted benzoazepines as toll-like receptor modulators |
07/19/2012 | WO2012097173A2 Substituted benzoazepines as toll-like receptor modulators |
07/19/2012 | WO2012097155A1 Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
07/19/2012 | WO2012097144A1 Lipid-lowering antidiabetic agent |
07/19/2012 | WO2012097133A2 Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic |
07/19/2012 | WO2012097121A2 Specific nnos inhibitors for the therapy and prevention of human melanoma |
07/19/2012 | WO2012097116A2 Isotopologues of isoindole derivatives |
07/19/2012 | WO2012097082A2 Method of optimizing 5-fu therapy |
07/19/2012 | WO2012097064A1 Nutritional compositions and methods for controlling blood glucose |
07/19/2012 | WO2012097062A1 Methods for treating or preventing cardiac and neurological disorders using chemokine receptor antagonists |
07/19/2012 | WO2012097054A1 Methods and compositions for treating cancer and related methods |
07/19/2012 | WO2012097052A2 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
07/19/2012 | WO2012097039A1 Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor |
07/19/2012 | WO2012097013A1 Irak inhibitors and uses thereof |
07/19/2012 | WO2012097000A1 Processes for preparing isoquinolinones and solid forms of isoquinolinones |
07/19/2012 | WO2012096985A1 Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
07/19/2012 | WO2012096977A1 Inhibitors of eya2 |
07/19/2012 | WO2012096939A2 Highly concentrated liquid acetaminophen solutions |
07/19/2012 | WO2012096934A2 Inhibitors of retroviral replication |
07/19/2012 | WO2012096929A2 Heteroaryl compounds and methods of use thereof |
07/19/2012 | WO2012096928A2 Pyrimidinone derivatives as fatty acid synthase inhibitors |
07/19/2012 | WO2012096919A1 Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors |
07/19/2012 | WO2012096906A1 Multifunctional topical formulation for the treatment of acne vulgaris and other skin conditions |
07/19/2012 | WO2012096904A1 Methods for treating prostatitis |
07/19/2012 | WO2012096887A2 Compositions comprising enzyme-cleavable oxycodone prodrug |
07/19/2012 | WO2012096884A1 Phenethylsulfone isoindoline derivatives as inhibitors of pde 4 and/or cytokines |
07/19/2012 | WO2012096873A1 Methods and drug products for treating alzheimer's disease |
07/19/2012 | WO2012096866A2 Use of beta-adrenergic inverse agonists for smoking cessation |
07/19/2012 | WO2012096839A1 Compositions for anorectal use and methods for treating anorectal disorders |
07/19/2012 | WO2012096832A2 Hdac inhibiting derivatives of camptothecin |
07/19/2012 | WO2012096722A1 Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
07/19/2012 | WO2012096718A2 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance |
07/19/2012 | WO2012096694A1 Novel n-halamine acrylamide monomers and copolymers thereof for biocidal coatings |
07/19/2012 | WO2012096654A1 Methods and compositions for treating cancer and related methods |
07/19/2012 | WO2012096632A1 New addition salts of ziprasidone, a process for the preparation thereof and use thereof in therapy |
07/19/2012 | WO2012096596A1 Antiviral agent |
07/19/2012 | WO2012096595A1 Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups |
07/19/2012 | WO2012096573A1 Mirna for treating diseases and conditions associated with neo-angiogenesis |
07/19/2012 | WO2012096556A1 Quinoxaline derivatives which are selective against trypanosoma cruzi and do not cause mutagenic effects |
07/19/2012 | WO2012096545A2 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
07/19/2012 | WO2012096494A2 Agent containing b-ring-substituted flavonoid derivatives for treating arthritis |
07/19/2012 | WO2012096458A2 Process for preparation of phenyl carbamate derivatives |
07/19/2012 | WO2012096399A1 Particle composition and pharmaceutical composition using particle composition |
07/19/2012 | WO2012096307A1 Novel glycosyltransferase gene and use thereof |
07/19/2012 | WO2012096183A1 Polymeric iron chelating agent |
07/19/2012 | WO2012096108A1 Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level |
07/19/2012 | WO2012095877A1 Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions |
07/19/2012 | WO2012095859A1 Polymorphs of dexlansoprazole salts |
07/19/2012 | WO2012095853A1 Modified release formulations comprising sip receptor modulators |
07/19/2012 | WO2012095836A1 Anti-angiogenic compound |
07/19/2012 | WO2012095820A1 Use of simalikalactone e as an anticancer agent |
07/19/2012 | WO2012095804A1 Means for reducing or eradicating the tumour capacity of cancer stem cells and/or metastatic stem cells. |
07/19/2012 | WO2012095792A1 Sugar derivatives having tensioactive and antimicrobial activity |
07/19/2012 | WO2012095781A1 Indazole derivatives as sodium channel inhibitors |
07/19/2012 | WO2012095774A1 Self assembled nanostructured saliva substitutes |
07/19/2012 | WO2012095731A1 Compositions for alleviating: stress, anxiety, depression and aiding with wight loss |
07/19/2012 | WO2012095726A1 Pharmaceutical combination containing glucosamine salts and paracetamol for the treatment of osteoarthritis |
07/19/2012 | WO2012095719A1 Melatonin and an antimicrobial or antibacterial agent for the treatment of acne |
07/19/2012 | WO2012095705A1 Pharmaceutically acceptable salts of novel betulinic acid derivatives |
07/19/2012 | WO2012095702A1 A composition for the regeneration of atrophic tissues |
07/19/2012 | WO2012095607A1 Preventive effect of citrulline on the spontaneous development of tumors |
07/19/2012 | WO2012095548A2 Compounds for treating neurodegenerative disorders |
07/19/2012 | WO2012095536A1 Implant comprising a core and a tube encasing the core |
07/19/2012 | WO2012095521A1 Bace-2 inhibitors for the treatment of metabolic disorders |
07/19/2012 | WO2012095511A1 Method for enhancing engraftment of haematopoetic stem cells |
07/19/2012 | WO2012095509A1 Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases |
07/19/2012 | WO2012095505A1 Anticancer therapy with dual aurora kinase / mek inhibitors |
07/19/2012 | WO2012095469A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
07/19/2012 | WO2012095463A1 Oxazine derivatives and their use in the treatment of neurological disorders |
07/19/2012 | WO2012095461A1 Beverage |
07/19/2012 | WO2012095459A1 Composition containing acetic acid, propanoic acid, butanoic acid, methylpropanoic acid and/or methylbutanoic acid |
07/19/2012 | WO2012095451A1 Crystalline oxazine derivative and its use as bace inhibitor |
07/19/2012 | WO2012095439A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions |
07/19/2012 | WO2012095438A1 Particles and suspensions of cephalosporin antibiotics |
07/19/2012 | WO2012095433A1 Compositions comprising 2-chloro-n- (4 - chloro - pyridin- 2 - yl - phenyl) - 4 -methanesulfonyl - benzamide and 2, 2 -dimethyl -n- ( (s) - 6-0x0-6, 7 - dihydro - 5h - dibenzo [b, d] azepin-7 -yl) -n' - (2,2,3,3,3- pentafluoro - propyl) malonamide |
07/19/2012 | WO2012095388A2 Compounds for treatment of feline leukemia in felidae |
07/19/2012 | WO2012095379A1 Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression |
07/19/2012 | WO2012095281A1 Amino acid composition and its use for treating intrauterine foetal growth restriction (iugr) or for parenteral nutrition of extremely pre-term infants |
07/19/2012 | WO2012095142A1 5-([1,2,3]triazole-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives |
07/19/2012 | WO2012094966A1 3-aryl-6-aryl-[1,2,4]triazolo[4,3-b]pyridazine as cell proliferation inhibiting agent and use thereof |
07/19/2012 | WO2012094949A1 Use of etomidate in preparation of drug for preventing or treating posttraumatic stress disorder |
07/19/2012 | WO2012094838A1 Use and pharmaceutical composition of lignosulfonate |